ORCHIDCHEM 
Orchid Chemicals & Pharmaceuticals Ltd
How do you think orchidchem will perform against the NIFTY? Pick this stock
CAPITAL4 COMMUNITY
All: Members who that have picked this stock: 60
58 outperforms
2 underperforms
Stars: Top Investors who have picked this stock: 0
0 outperforms
0 underperforms
CLASSIFICATION | SECTOR | INDUSTRY |
|---|---|---|
| Primary | Pharma & Healthcare | Pharmaceuticals |
SNAPSHOT
- BSE Code / NSE Ticker
- 524372 / ORCHIDCHEM
- Last traded time
- 2012-05-23 15:59:09
- Last traded on
- BSE
- Intra-day Low / High
- 117.4 / 124.1
- 52w closing Low / High
- 119.3 / 292.0
- Today Volume
- 2,898,530
- 30d avg Daily Volume
- 2,391,259
- Market Cap
- INR 840.5 cr
- P/E Ratio TTM
- 7.85
- Historical Performance
- Today
- Weekly
- Monthly
- 3 Months
- 1 Year
- -3.6%
- -6.2%
- -33.8%
- -33.6%
- -54.4%
valuation snapshotpeer comparisonfinancialsshare holdingmf holdingcommunity picksbrokerage picks futures & options
P&L Account Balance Sheet Cashflow Stmt Qtrly Result Consolidated P&L Consolidated BS Consolidated CF
Source: Capital Market
All values are in Rs. cr.
| Particulars | Mar 2011 | Mar 2010 | Mar 2009 | Mar 2008 | Mar 2007 | Mar 2006 |
| INCOME : | ||||||
| Sales Turnover | 1680.80 | 1258.54 | 1203.21 | 1250.18 | 934.18 | 888.77 |
| Excise Duty | 17.46 | 8.71 | 11.77 | 11.26 | 21.26 | 15.31 |
| Net Sales | 1663.34 | 1249.83 | 1191.44 | 1238.92 | 912.92 | 873.46 |
| Other Income | 7.60 | 1025.10 | 90.15 | 72.90 | 29.94 | 16.60 |
| Stock Adjustments | 119.64 | -269.45 | 64.78 | 19.34 | 140.12 | 19.13 |
| Total Income | 1790.58 | 2005.48 | 1346.37 | 1331.16 | 1082.98 | 909.19 |
| EXPENDITURE : | ||||||
| Raw Materials | 907.60 | 505.81 | 575.09 | 453.99 | 450.68 | 383.20 |
| Power & Fuel Cost | 72.54 | 66.44 | 73.45 | 69.58 | 52.02 | 43.22 |
| Employee Cost | 141.38 | 159.29 | 122.89 | 99.89 | 77.73 | 65.21 |
| Other Manufacturing Expenses | 118.35 | 70.85 | 65.90 | 75.53 | 56.31 | 49.78 |
| Selling and Administration Expenses | 168.60 | 211.98 | 162.91 | 157.84 | 124.09 | 94.97 |
| Miscellaneous Expenses | -35.91 | 138.73 | 97.81 | 56.60 | 30.36 | 11.92 |
| Less: Pre-operative Expenses Capitalised | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenditure | 1372.56 | 1153.10 | 1098.05 | 913.43 | 791.19 | 648.30 |
| Operating Profit | 418.02 | 852.38 | 248.32 | 417.73 | 291.79 | 260.89 |
| Interest | 115.77 | 241.23 | 155.19 | 81.51 | 98.73 | 87.30 |
| Gross Profit | 302.25 | 611.15 | 93.13 | 336.22 | 193.06 | 173.59 |
| Depreciation | 128.45 | 151.10 | 129.97 | 97.67 | 82.47 | 82.98 |
| Profit Before Tax | 173.80 | 460.05 | -36.84 | 238.55 | 110.59 | 90.61 |
| Tax | 23.57 | 54.39 | 0.00 | 29.09 | 0.00 | 0.00 |
| Fringe Benefit tax | 0.00 | 0.00 | 1.61 | 1.50 | 1.66 | 1.81 |
| Deferred Tax | -9.25 | 74.32 | 13.72 | 23.42 | 12.30 | 5.90 |
| Reported Net Profit | 159.48 | 331.34 | -52.17 | 184.54 | 96.63 | 82.90 |
| Extraordinary Items | 0.50 | 884.90 | -1.32 | -0.10 | -0.33 | 0.37 |
| Adjusted Net Profit | 158.98 | -553.56 | -50.85 | 184.64 | 96.96 | 82.53 |
| Adjst. below Net Profit | 21.74 | 2.47 | 9.63 | 11.29 | 2.68 | 0.00 |
| P & L Balance brought forward | 58.59 | 28.32 | 81.57 | 40.10 | 45.19 | 27.48 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 179.72 | 303.54 | 10.71 | 154.36 | 104.40 | 65.19 |
| P & L Balance carried down | 60.09 | 58.59 | 28.32 | 81.57 | 40.10 | 45.19 |
| Dividend | 25.57 | 88.79 | 9.16 | 29.37 | 29.40 | 22.09 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend % | 30.00 | 100.00 | 10.00 | 30.00 | 30.00 | 30.00 |
| Dividend Per Share(Rs) | 3.00 | 10.00 | 1.00 | 3.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 22.05 | 44.94 | 0.00 | 27.27 | 13.92 | 12.35 |
| Earnings Per Share(Adj)-Unit Curr | 22.05 | 44.94 | 0.00 | 27.27 | 13.92 | 12.35 |
| Book Value-Unit Curr | 160.99 | 139.07 | 95.15 | 104.49 | 76.15 | 121.48 |
| Book Value(Adj)-Unit Curr | 160.99 | 139.07 | 95.15 | 104.49 | 76.15 | 121.48 |
Source: Capital Market
CAPITAL4 COMMUNITY
STOCK SCREENERS
INDIA CAPITAL MARKETS
ORCHIDCHEM IN THE NEWS
- May-16 8:07 Orchid Chemicals & Pharmaceuticals net profit declines 66.47% in the March 2012 quarter
- May-08 12:39 Orchid Pharma receives USFDA approval for Naratriptan Tabs ANDA
- May-08 11:09 Orchid Chemicals & Pharmaceuticals to consider dividend
- Apr-05 9:25 Hon'ble High Court approves scheme of amalgamation of Orchid Chemicals & Pharmaceuticals
- Feb-08 15:00 Orchid Chemicals & Pharmaceuticals reports net loss of Rs 10.12 crore in the December 2011 quarter
- Feb-07 11:07 Orchid Chemicals & Pharmaceuticals receives USFDA approval
- Jan-11 9:56 Orchid Chemicals & Pharmaceuticals' board approves scheme of amalgamation
- Dec-30 16:28 Orchid Chemicals & Pharmaceuticals to hold board meeting
- Dec-23 11:28 Orchid's drug discovery research initiative with Merck advances anti-infective program meets preclinical milestone
TOP BLOGS
- Advice for – Tuesday, May 22, 2012
by ABHISHEK-PARAKH
(Recommendations: 6) - Money can be made in all market conditions
by ASHOKSHARMA
(Recommendations: 7) - The problem with historical returns
by ROHIT CHAUHAN
(Recommendations: 9) - Markets: What next?
by Nishit_Vadhavkar
(Recommendations: 8) - Nifty – RSI at sub 30. Highly Oversold – Bottoming out in next few sessions
by NOORESH MERANI
(Recommendations: 9) - Follow up: Gujarat reclaim & rubber products ltd
by ROHIT CHAUHAN
(Recommendations: 9) - Negative news drags the markets down
by Nishit_Vadhavkar
(Recommendations: 7) - Option strategy worked will in such unpredictable market
by ASHOKSHARMA
(Recommendations: 8) - Sensex- Technical Outlook and Trading Levels, 8 April 2012
by D_Sathiamoorthy
(Recommendations: 5) - Insourcing vs. outsourcing government functions: A setback for public sector production of elementary education
by AJAY SHAH
(Recommendations: 7) - Crucial Week Ahead
by Nishit_Vadhavkar
(Recommendations: 8) - A few contrarian thoughts
by ROHIT CHAUHAN
(Recommendations: 8)
Company and Mutual Fund Finder
| Company: | 3ABCDEFGHIJKLMNOPQRSTUVWXYZ |
| Indices: | NIFTY | SENSEX | BSE 100 | BSE 200 | BSE 500 | BSE MIDCAP | BSE SMALLCAP | BSE AUTO | BSE BANKEX | BSE CD | BSE CG | BSE FMCG | BSE HC | BSE IT | BSE METAL | BSE OIL | BSE POWER | BSE PSU | BSE REALTY | BSE TECK | BSE DOLLEX | DOLLEX 100 | DOLLEX 200 | NIFTY JUNIOR | CNX MIDCAP | NIFTY MID50 | BANK NIFTY | CNX IT | CNX100 | CNX 500 | CNX DEFTY |
| Mutual Funds: | AIG Global Investment | AXIS | Baroda Pioneer | Benchmark | Bharti AXA | Birla Sun Life | Canara Robeco | Deutsche | DSP BlackRock | Edelweiss | Escorts | Fidelity | Fortis | Franklin Templeton | HDFC | HSBC | ICICI Prudential | IDBI | IDFC | ING | JM Financial | JP Morgan | Kotak Mahindra | L&T | LIC | Mirae Asset | Morgan Stanley | Motilal Oswal | Peerless | Pramerica | PRINCIPAL | Quantum | Reliance | Religare | Sahara | SBI | Shinsei | Sundaram BNP Paribas | Tata | Taurus | UTI |